- ►nih.gov - Free from Publisher JI Patel, PG Hykin, ZJ Gregor, M Boulton, IA … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Results: Angiopoietin 1 concentrations were low in patients with macular hole
(median 17 pg/ml) while in NPDR with CSMO they were 2002 pg/ml (range 289–5820
pg/ml) and in PDR 186 pg/ml (range 26–2292 pg/ml). Angiopoietin 2 ... Cited by 15 - Related articles - All 10 versions
- ►nih.gov N Oishi, E Kubo, Y Takamura, K Maekawa, T … - British Journal of Ophthalmology, 2002 - bjo.bmj.com Methods: A clinic based cross sectional study was used. 611 NIDDM patients and
73 controls were enrolled. Erythrocyte AR levels were determined by ELISA. These
AR levels were then correlated with patient age, duration of diabetes, and ... Cited by 11 - Related articles - BL Direct - All 8 versions
[CITATION] Selective VEGF inhibition: effectiveness in modifying the progression of proliferative diabetic …
Z Zheng, H Chen, X Xu, C Li, Q Gu - Experimental eye research, 2007 - Elsevier Vascular endothelial growth factor (VEGF) plays a pivotal role in diabetic
retinopathy (DR) and hypertension has been identified as an independent risk
factor for DR. The aim of the present study was to: (1) explore whether β- ... Cited by 6 - Related articles - All 4 versions
M Yokoi, S Yamagishi, M Takeuchi, T Matsui … - British Medical Journal, 2007 - bjo.bmj.com We investigated whether vitreous levels of advanced glycation end products
(AGEs) were positively correlated with vascular endothelial growth factor (VEGF)
in patients with diabetic retinopathy patients sufficiently treated with ... Cited by 7 - Related articles - All 5 versions
H Song, L Wang, Y Hui - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Aim To investigate the expression of CD18 on neutrophils from patients
with various stages of diabetic retinopathy (DR) and to determine the
possibility of using it as a marker of disease development. Research design ... Cited by 9 - Related articles - BL Direct - All 3 versions
MJ Taverna, A Sola, C Guyot-Argenton, N … - Diabetologia, 2002 - Springer Neovascularization plays a role in determining the se- verity of diabetic
retinopathy (DR) due to the effects of several angiogenic and growth factors,
including vascular endothelial growth factor (VEGF), platelet- derived ... Cited by 25 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] N Chaturvedi - Heart, 2000 - pubmedcentral.nih.gov Pathology The earliest detectable lesions of diabetic retinopathy are
microaneurysms. These are associated with excessive vascular permeability and
result in exudate formation. There is occlusion of the vessels and ... Cited by 26 - Related articles - BL Direct - All 6 versions
MG Petrovič, B Peterlin, M Hawlina, D … - Journal of diabetes and its complications, 2005 - Elsevier Genetic factors are implicated in the development of diabetic retinopathy, and
the aldose reductase (AC)n gene is a candidate gene for the development of
diabetic retinopathy in patients with Type 2 diabetes. In the association ... Cited by 13 - Related articles - All 8 versions
- ►shouxi.net SY Kim, MA Johnson, DS McLeod, T … - Diabetes, 2005 - Am Diabetes Assoc Type 2 diabetes develops spontaneously in obese aging rhesus monkeys (Macaca
mulatta). This study investigates the association between polymorphonuclear
leukocytes and development of retinopathy. Blood pressure and plasma ... Cited by 13 - Related articles - All 5 versions
